Inhibition of TRPM3 by Primidone Provides a Potential Therapeutic Method for Adenomyosis Management
The expression profile of TRP channels varies significantly in adenomyosis patients, and primidone may provide a potential therapeutic method for adenomyosis management.
Authors
- Zhixing Jin (ORCID: https://orcid.org/0000-0002-1241-1048)
- Xiaoping He (ORCID: https://orcid.org/0000-0002-0697-6501)
- Yaoming Peng
- Qianqian Yang (ORCID: https://orcid.org/0000-0002-4331-5059)
- Yi Zhang (ORCID: https://orcid.org/0000-0001-9861-4681)
- Man Li (ORCID: https://orcid.org/0000-0002-3839-0281)
- He Zhang (ORCID: https://orcid.org/0000-0001-5877-2167)
- Xin Pan (ORCID: https://orcid.org/0000-0003-0529-6229)
Institutions
- Soochow University (CN)
- Obstetrics and Gynecology Hospital of Fudan University (CN)
- First Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/dddt.s494981
- Citations
- 1
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.70